Successful treatment of encapsulating peritoneal sclerosis by hemodialysis and peritoneal lavage using dialysate containing dissolved hydrogen

Perit Dial Int. 2015 Jan-Feb;35(1):107-12. doi: 10.3747/pdi.2013.00255.

Authors

Hiroyuki Terawaki¹, Hirofumi Nakano², Wan-Jun Zhu², Masaaki Nakayama²

Affiliations

¹ Dialysis center Fukushima Medical University, Fukushima, Japan Department of Internal Medicine Kashima Hospital, Iwaki, Japan Department of Nephrology Fukushima Medical Hospital, Fukushima, Japan terawaki@fmu.ac.jp.
² Dialysis center Fukushima Medical University, Fukushima, Japan Department of Internal Medicine Kashima Hospital, Iwaki, Japan Department of Nephrology Fukushima Medical Hospital, Fukushima, Japan.

No abstract available

Publication types

Case Reports

MeSH terms

Biopsy, Needle
Combined Modality Therapy
Diabetic Nephropathies / diagnosis
Diabetic Nephropathies / therapy*
Dialysis Solutions / chemistry
Follow-Up Studies
Humans
Hydrogen / pharmacology
Immunohistochemistry
Male
Middle Aged
Peritoneal Dialysis, Continuous Ambulatory / adverse effects*
Peritoneal Dialysis, Continuous Ambulatory / methods
Peritoneal Fibrosis / etiology
Peritoneal Fibrosis / pathology
Peritoneal Fibrosis / therapy*
Peritoneal Lavage / methods*
Renal Dialysis / methods*
Risk Assessment
Severity of Illness Index
Treatment Outcome

Substances

Dialysis Solutions
Hydrogen